These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2860720)
21. [Treatment of rheumatoid spondylarthritis with salazosulfapyridine]. Hilliquin P; Munoz A; Menkès CJ Rev Rhum Mal Osteoartic; 1991; 58(7):535-41. PubMed ID: 1681585 [TBL] [Abstract][Full Text] [Related]
22. Sulphasalazine induced immunodeficiency. Savilahti E Br Med J (Clin Res Ed); 1983 Sep; 287(6394):759. PubMed ID: 6137259 [No Abstract] [Full Text] [Related]
23. Immunological studies in two children of a mother with IgA deficiency and anti-IgA antibodies. Weemaes C; van Munster P; Bakkeren J Clin Immunol Immunopathol; 1982 Apr; 23(1):145-51. PubMed ID: 6980071 [No Abstract] [Full Text] [Related]
24. Good response to D-penicillamine in IgA-deficient rheumatoid arthritis. Mbuyi-Muamba JM; Stevens E; Dequeker J Scand J Rheumatol; 1981; 10(1):31-2. PubMed ID: 7221493 [No Abstract] [Full Text] [Related]
25. IgA deficiency and drug induced IgA deficiency in rheumatoid arthritis. Mbuyi JM; Dequeker J; Francx L J Rheumatol; 1983 Oct; 10(5):829-31. PubMed ID: 6644713 [No Abstract] [Full Text] [Related]
26. Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods. Situnayake RD; Grindulis KA; McConkey B Ann Rheum Dis; 1987 Mar; 46(3):177-83. PubMed ID: 2883939 [TBL] [Abstract][Full Text] [Related]
27. [Anti-IgA antibodies in rheumatoid arthritis]. Kemp M; Rasmussen JM; Svehag SE Ugeskr Laeger; 1987 Feb; 149(7):433-5. PubMed ID: 3493575 [No Abstract] [Full Text] [Related]
29. [Two-phase course of IgM and rheumatoid factors during D-penicillamine therapy]. Stojan B; Hasler F Z Rheumatol; 1977; 36(5-6):194-9. PubMed ID: 302538 [TBL] [Abstract][Full Text] [Related]
30. Anti-IgA in selective IgA deficiency. In vitro effects and Ig subclass pattern of human anti-IgA. Hammarström L; Persson MA; Smith CI Scand J Immunol; 1983 Dec; 18(6):509-13. PubMed ID: 6607511 [TBL] [Abstract][Full Text] [Related]
32. [Pharmachem's salazopyrine in rheumatoid arthritis]. Konstantinova M; Konstantinova V Vutr Boles; 1990; 29(5):65-8. PubMed ID: 1981958 [TBL] [Abstract][Full Text] [Related]
33. [Selective IgA deficiency in patients with systemic lupus erythematosus and rheumatoid arthritis]. Kuştimur S; Gülmezoğlu E Mikrobiyol Bul; 1985 Oct; 19(4):190-9. PubMed ID: 3879527 [TBL] [Abstract][Full Text] [Related]
34. Selective IgA deficiency in Australian blood donors. Wells JV; McNally MP; King MA Aust N Z J Med; 1980 Aug; 10(4):410-3. PubMed ID: 6968556 [TBL] [Abstract][Full Text] [Related]
35. HLA association of anti-IgA antibody production. Strothman RA; Sedestrom LM; Ball MJ; Chen SN Tissue Antigens; 1989 Aug; 34(2):141-4. PubMed ID: 2609324 [TBL] [Abstract][Full Text] [Related]
36. [Effect of D-penicillamine on the latex fixation test, hemagglutination test and streptococci-L-agglutination in vitro]. Keil E; Schütz M; Tanner E; Seidel K Z Gesamte Inn Med; 1971 Jan; 26(2):83-5. PubMed ID: 5314856 [No Abstract] [Full Text] [Related]
37. IgM cryoprecipitation and anti-immunoglobulin activity in dysgammaglobulinemia type I. Winfield JB; Cohen PL; Bradley L; Finkelman FD; Eisenberg RA; Wistar R; Whisnant JK Clin Immunol Immunopathol; 1982 Apr; 23(1):58-69. PubMed ID: 6980073 [No Abstract] [Full Text] [Related]
38. Persistent and transient IgA deficiency in juvenile rheumatoid arthritis. Pelkonen P; Savilahti E; Mäkelä AL Scand J Rheumatol; 1983; 12(3):273-9. PubMed ID: 6623018 [TBL] [Abstract][Full Text] [Related]
39. Gammaglobulin treatment and anti-IgA antibodies in IgA-deficient patients. Koistinen J; Heikkilä M; Leikola J Br Med J; 1978 Sep; 2(6142):923-4. PubMed ID: 81700 [TBL] [Abstract][Full Text] [Related]